Chair and Clinical Department of Internal Diseases, Dermatology and Allergology ul. M. Curie-Skłodowskiej 10, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland.
Biomed Res Int. 2013;2013:823798. doi: 10.1155/2013/823798. Epub 2013 Oct 23.
Elevated levels of soluble CD40 Ligand (sCD40L) were found in serum but not in plasma of patients with chronic spontaneous urticaria (CU). What is important is that sCD40L has proinflammatory properties, and its elevated plasma level may indicate increased risk of cardiovascular events. These observations should stimulate further evaluation of sCD40L in different forms of urticaria.
In the present study, sCD40L plasma level was investigated in delayed pressure urticaria (DPU).
As platelets are predominant and variable sources of sCD40L, we investigated sCD40L concentration in platelet-poor plasma (PPP), which seems the best way to minimize the potential contribution of these cells to the ligand level.
Plasma sCD40L concentration was significantly increased in the DPU group compared to the healthy controls.
It seems that DPU is associated with increased systemic release of sCD40L, which is believed to derive predominantly from activated platelets. The present study as well as the earlier contributions suggest that distinct cells activity, including platelets, may be identified in different types of urticaria.
在慢性自发性荨麻疹(CU)患者的血清中发现可溶性 CD40 配体(sCD40L)水平升高,但在血浆中未发现。重要的是,sCD40L 具有促炎特性,其血浆水平升高可能表明心血管事件的风险增加。这些观察结果应刺激对不同形式荨麻疹中 sCD40L 的进一步评估。
本研究旨在研究迟发性压力性荨麻疹(DPU)患者的血浆 sCD40L 水平。
由于血小板是 sCD40L 的主要和可变来源,我们研究了富含血小板的血浆(PPP)中的 sCD40L 浓度,这似乎是最大限度减少这些细胞对配体水平潜在贡献的最佳方法。
与健康对照组相比,DPU 组血浆 sCD40L 浓度显著升高。
DPU 似乎与 sCD40L 的全身性释放增加有关,据信这些 sCD40L 主要来自活化的血小板。本研究以及早期的研究表明,不同类型的荨麻疹中可能存在不同的细胞活性,包括血小板。